ADD CONDITION

items per page

Robohbr Cough Suppressant

Last content change checked dailysee data sync status

Active ingredient
Dextromethorphan Hydrobromide 30 mg
Other brand names
Drug classes
Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Dosage form
Tablet
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2022
Label revision date
October 6, 2025
Active ingredient
Dextromethorphan Hydrobromide 30 mg
Other brand names
Drug classes
Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Dosage form
Tablet
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2022
Label revision date
October 6, 2025
Manufacturer
DXM Pharmaceutical, Inc
Registration number
M012
NDC root
71598-100

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may find that this medication is designed to temporarily relieve cough caused by minor irritation in the throat and bronchial tubes, which can happen with the common cold. It helps soothe your throat and reduce the urge to cough, making you feel more comfortable during your recovery.

Uses

You can use this medication to temporarily relieve a cough caused by minor irritation in your throat and bronchial tubes, which often happens with the common cold. This means that if you're feeling uncomfortable due to a cough associated with a cold, this medication may help ease that symptom.

It's important to note that there are no reported teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects (which refers to other types of harmful effects) associated with this medication. This makes it a safer option for those concerned about potential risks.

Dosage and Administration

It's important to use this medication exactly as directed by your doctor or according to the instructions provided. For adults and children aged 12 years and older, you can take 1 tablet every 6 to 8 hours as needed, but make sure not to exceed 4 tablets in a 24-hour period.

If you have children under 12 years of age, this product is not suitable for them, so please avoid using it for that age group. Always follow these guidelines to ensure safe and effective use of the medication.

What to Avoid

It's important to ensure that you use this medication safely. Always keep it out of reach of children to prevent accidental ingestion. In the event of an overdose, seek medical assistance immediately or contact a Poison Control Center at 1-800-222-1222 for guidance.

While there are no specific contraindications, controlled substance classifications, or noted risks of abuse or dependence associated with this medication, your safety is paramount. Always follow the instructions provided and consult with your healthcare provider if you have any questions or concerns.

Side Effects

You should be aware of some important warnings and potential side effects when using this medication. Avoid taking it if you are currently on a monoamine oxidase inhibitor (MAOI), which is a type of medication used for depression or certain other conditions, or if you have stopped taking an MAOI within the last two weeks. If you have a cough that produces a lot of mucus or a chronic cough related to smoking, asthma, or emphysema, consult your doctor before using this medication.

It's also crucial to stop using the medication and seek medical advice if your cough lasts more than a week, keeps coming back, or is accompanied by symptoms like fever, rash, or a persistent headache, as these could indicate a more serious health issue. If you are pregnant or breastfeeding, please consult a healthcare professional before using this medication.

Warnings and Precautions

You should not use this product if you are currently taking a prescription monoamine oxidase inhibitor (MAOI), which is a type of medication used for depression or certain other conditions. If you have recently stopped taking an MAOI, wait at least two weeks before using this product. If you're unsure whether your medication contains an MAOI, please consult your doctor or pharmacist.

Before using this product, it's important to talk to your doctor if you have a cough with excessive mucus or a chronic cough related to smoking, asthma, or emphysema. If your cough lasts more than a week, keeps coming back, or is accompanied by fever, rash, or a persistent headache, stop using the product and contact your doctor, as these could be signs of a more serious issue. If you are pregnant or breastfeeding, consult a healthcare professional before use.

In case of an overdose, seek emergency medical help immediately or contact a Poison Control Center at 1-800-222-1222.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

This product is specifically designed for adults and should not be used in children under 12 years of age. If your child is younger than 12, it is important to avoid using this medication altogether. Always consult with a healthcare professional if you have questions about appropriate treatments for your child.

Geriatric Use

This product is designed for adults and is not suitable for children under 12 years of age. For older adults, there are no specific dosage adjustments or safety concerns mentioned, which means you can use it as directed without special precautions. However, it's always a good idea to consult with your healthcare provider to ensure that any medication is appropriate for your individual health needs.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to consult with your healthcare provider about your specific situation, as they can offer personalized advice and ensure that any medications you take are safe and effective for you.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular liver function tests (which check how well your liver is working) to ensure your safety while using any medication.

Drug Interactions

It's important to be cautious when taking dextromethorphan, especially if you have recently used monoamine oxidase inhibitors (MAOIs), a type of medication often used to treat depression. Using dextromethorphan with MAOIs can lead to serious interactions, so you should wait at least two weeks after stopping an MAOI before starting dextromethorphan.

Always discuss any medications you are taking with your healthcare provider to ensure your safety and avoid potential interactions. This includes informing them about any recent treatments or medications, as they can help guide you on the best course of action.

Storage and Handling

To ensure the safety and effectiveness of your product, store it at a temperature between 20-25°C (68-77°F). This helps maintain its quality and performance.

When handling the product, be sure to check the safety seal under the child-resistant cap. If the seal is broken or missing, do not use the product, as this indicates it may have been tampered with. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should take this medication orally. If you are pregnant or breastfeeding, it's important to consult a healthcare professional before using it. Always keep this medication out of reach of children. In the event of an overdose, seek medical help immediately or contact a Poison Control Center at 1-800-222-1222.

FAQ

What is the purpose of this medication?

This medication temporarily relieves cough due to minor throat and bronchial irritation that may occur with the common cold.

Who should not use this product?

This product is not intended for use in children under 12 years of age.

What is the recommended dosage for adults and children 12 years and over?

You should take 1 tablet every 6 to 8 hours as needed, but do not exceed 4 tablets in any 24-hour period.

What should I do in case of overdose?

In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

Are there any warnings I should be aware of?

Do not use this product if you are currently taking a monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping an MAOI. Consult a doctor if you have a cough with excessive phlegm or a persistent cough.

What should I do if my cough persists?

Stop use and ask a doctor if your cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache.

Is it safe to use this medication if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, you should ask a health professional before using this medication.

How should I store this medication?

Store the medication at 20-25°C (68-77°F) and do not use it if the safety seal under the child-resistant cap is broken or missing.

Packaging Info

Below are the non-prescription pack sizes of Robohbr Cough Suppressant (dextromethorphan hbr). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Robohbr Cough Suppressant.
Details

Drug Information (PDF)

This file contains official product information for Robohbr Cough Suppressant, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available.

Uses and Indications

This drug is indicated for the temporary relief of cough associated with minor throat and bronchial irritation, which may occur due to the common cold.

Limitations of Use: There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product should be used strictly according to the provided directions or as directed by a healthcare professional.

For adults and children aged 12 years and older, the recommended dosage is 1 tablet every 6 to 8 hours as needed. It is important not to exceed a total of 4 tablets within a 24-hour period.

This product is not intended for use in children under 12 years of age.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222.

Warnings and Precautions

The use of this product is contraindicated in individuals currently taking a prescription monoamine oxidase inhibitor (MAOI), which includes certain medications prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease. Additionally, it should not be used for a period of two weeks following the discontinuation of an MAOI. Healthcare professionals should advise patients to consult with a doctor or pharmacist if there is uncertainty regarding the presence of an MAOI in their prescription medications.

Healthcare professionals should exercise caution and recommend that patients seek medical advice prior to using this product if they are experiencing a cough that is accompanied by excessive phlegm (mucus) or if they have a persistent or chronic cough, such as those associated with smoking, asthma, or emphysema.

Patients should be instructed to discontinue use and consult a healthcare provider if a cough persists for more than one week, recurs, or is accompanied by additional symptoms such as fever, rash, or persistent headache. A persistent cough may indicate an underlying serious condition that requires further evaluation.

For individuals who are pregnant or breastfeeding, it is essential to seek guidance from a healthcare professional before using this product to ensure safety for both the mother and child.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222.

Healthcare providers should remain vigilant in monitoring patients for the aforementioned symptoms and conditions to ensure safe and effective use of this product.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. Serious warnings include the contraindication of use in individuals currently taking a monoamine oxidase inhibitor (MAOI) or within two weeks of discontinuing such medication, which is commonly prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease.

Before initiating treatment, patients are advised to consult a healthcare professional if they experience a cough accompanied by excessive phlegm or if they have a persistent or chronic cough, such as those associated with smoking, asthma, or emphysema. It is crucial to discontinue use and seek medical advice if a cough persists for more than one week, recurs, or is accompanied by additional symptoms such as fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

For pregnant or breastfeeding patients, it is recommended to consult a healthcare professional prior to use to ensure safety for both the mother and child.

Drug Interactions

Dextromethorphan is contraindicated for use in conjunction with monoamine oxidase inhibitors (MAOIs) due to the potential for serious interactions. It is recommended that a minimum of two weeks should elapse after discontinuation of an MAOI before initiating treatment with dextromethorphan to mitigate the risk of adverse effects.

No additional drug interactions or laboratory test interactions have been identified for dextromethorphan.

Packaging & NDC

Below are the non-prescription pack sizes of Robohbr Cough Suppressant (dextromethorphan hbr). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Robohbr Cough Suppressant.
Details

Pediatric Use

This product is not intended for use in pediatric patients under 12 years of age. The safety and efficacy of this medication have not been established in children younger than 12, and its use in this population is contraindicated.

Geriatric Use

Elderly patients, defined as those aged 65 years and older, may use this adult product; however, it is important to note that the product is not intended for use in children under 12 years of age.

The prescribing information does not specify any dosage adjustments or safety concerns specifically related to geriatric patients. Additionally, there are no special precautions outlined for elderly patients in the provided text.

Healthcare providers should continue to monitor elderly patients for any potential adverse effects, as individual responses to medication can vary.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on managing overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies in the event of an overdose.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

Reports of serious adverse events associated with the use of this product have been received through voluntary reporting and surveillance programs. Healthcare professionals and patients are encouraged to report any such events. For inquiries or to report adverse events, individuals may contact the designated support line on weekdays between 10 a.m. to 4 p.m. CST at 833-289-7626 or visit the official website at www.RoboCough.com. It is advised that medical advice be sought from a healthcare provider for any health-related concerns.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important for patients to understand the potential risks associated with overdose. In the event of an overdose, patients should be instructed to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222 for assistance.

Storage and Handling

The product is supplied in a configuration that includes a child-resistant cap with a safety seal. It is essential to store the product at a temperature range of 20-25°C (68-77°F) to maintain its integrity and efficacy.

The packaging is designed to be tamper evident; therefore, the product should not be used if the safety seal under the child-resistant cap is broken or missing. Proper handling and storage conditions are crucial to ensure the product remains safe for use.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is crucial to keep the medication out of reach of children, and in the event of an overdose, patients should seek medical assistance or contact a Poison Control Center immediately at 1-800-222-1222. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Robohbr Cough Suppressant, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Robohbr Cough Suppressant, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.